Literature DB >> 28682425

Fas/FasL induces myocardial cell apoptosis in myocardial ischemia-reperfusion rat model.

X-M Liu1, Z-M Yang, X-K Liu.   

Abstract

OBJECTIVE: Myocardium ischemia reperfusion is easy to induce myocardial injury. Fas/FasL is an important signaling pathway mediating cell apoptosis. This study aims to analyze the cell apoptosis and Fas/FasL expression in myocardial cell ischemia reperfusion rat model.
MATERIALS AND METHODS: Coronary artery ligation method was used to establish myocardial ischemia reperfusion model. Rats were grouped according to different ischemia and reperfusion time: Group A, myocardial ischemia for 30 min and reperfusion for 24 h; Group B, myocardial ischemia for 30 min and reperfusion for 48 h; Group C, myocardial ischemia for 1 h and reperfusion for 24 h. Myocardial injury indicators were tested. Myocardial cell apoptosis was detected by transferase-mediated deoxyuridine triphosphate-biotin nick end labeling (TUNEL) assay. Fas and FasL mRNA and protein expressions were evaluated by Real-time PCR (RT-PCR) and Western blot.
RESULTS: Creatine kinase (CK), lactic dehydrogenase  (LDH), and malondialdehyde (MDA) significantly elevated, while superoxide dismutase (SOD) obviously declined in the experimental group compared with control and blank group (p<0.05). CK, LDH, and MDA gradually upregulated, whereas SOD was reduced in experimental groups following the time extension of ischemia and reperfusion (p<0.05). Apoptosis cell number was markedly higher in the experimental group compared with control and blank group (p<0.05). Apoptosis cell number gradually increased in the experimental groups following ischemia and reperfusion time extension (p<0.05). Fas/FasL mRNA and protein markedly upregulated in the experimental group compared with control and blank group (p<0.05). Fas/FasL mRNA and protein expressions enhanced in experimental groups following the time extension of ischemia and reperfusion (p<0.05).
CONCLUSIONS: Fas/FasL induces myocardial cell apoptosis in the process of myocardium ischemia reperfusion in rat model.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28682425

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  8 in total

1.  MicroRNA-214-5p protects against myocardial ischemia reperfusion injury through targeting the FAS ligand.

Authors:  Yuan Lu; Jue Xi; Yao Zhang; Chenzong Li; Wensu Chen; Xiaoqin Hu; Min Zhang; Fengyun Zhang; Hui Wei; Zhi Li; Zhirong Wang
Journal:  Arch Med Sci       Date:  2019-05-28       Impact factor: 3.318

2.  Eriodictyol Attenuates Myocardial Ischemia-Reperfusion Injury through the Activation of JAK2.

Authors:  Defang Li; Ning Lu; Jichun Han; Xiaoyu Chen; Wenjin Hao; Wenjuan Xu; Xiaona Liu; Lei Ye; Qiusheng Zheng
Journal:  Front Pharmacol       Date:  2018-01-30       Impact factor: 5.810

3.  Astragaloside IV reduces cardiomyocyte apoptosis in a murine model of coxsackievirus B3-induced viral myocarditis.

Authors:  Tianlong Liu; Fan Yang; Jing Liu; Mingjie Zhang; Jianjun Sun; Yunfeng Xiao; Zhibin Xiao; Haiyan Niu; Ruilian Ma; Yi Wang; Xiaolei Liu; Yu Dong
Journal:  Exp Anim       Date:  2019-06-26

4.  Visnagin ameliorates myocardial ischemia/reperfusion injury through the promotion of autophagy and the inhibition of apoptosis.

Authors:  Hai-Rong Fu; Xiao-Shan Li; Yong-Hui Zhang; Bin-Bin Feng; Lian-Hong Pan
Journal:  Eur J Histochem       Date:  2020-09-07       Impact factor: 3.188

5.  Inhibition of TNF-α and JNK Signaling Pathway Can Reduce Paclitaxel-Induced Apoptosis of Mouse Cardiomyocytes.

Authors:  Shuang Ren; Tianwen Huang; Danyan Ou; Luhuai Feng; Sisi Huang; Chaonan Zhou; Lianying Ge
Journal:  Appl Bionics Biomech       Date:  2022-08-16       Impact factor: 1.664

6.  c-Myc promotes tubular cell apoptosis in ischemia-reperfusion-induced renal injury by negatively regulating c-FLIP and enhancing FasL/Fas-mediated apoptosis pathway.

Authors:  Dan Xu; Bao Wang; Pan-Pan Chen; Yan-Zhe Wang; Nai-Jun Miao; Fan Yin; Qian Cheng; Zhuan-Li Zhou; Hong-Yan Xie; Li Zhou; Jun Liu; Xiao-Xia Wang; Hong Xue; Wei Zhang; Li-Min Lu
Journal:  Acta Pharmacol Sin       Date:  2018-12-28       Impact factor: 6.150

7.  Sheng Mai San protects H9C2 cells against hyperglycemia-induced apoptosis.

Authors:  Bing Pang; Li-Wei Shi; Li-Juan Du; Yun-Chu Li; Mei-Zhen Zhang; Qing Ni
Journal:  BMC Complement Altern Med       Date:  2019-11-12       Impact factor: 3.659

8.  Epigallocatechin-3-gallate protects cardiomyocytes from hypoxia-reoxygenation damage via raising autophagy related 4C expression.

Authors:  Ping Liu; Jin Huang; Wanzhen Mei; Xingfang Zeng; Cheng Wang; Chuan Wen; Jing Xu
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.